As Alcon Shareholders Fight Back, Will Novartis Sweeten Its Merger Offer?
This article was originally published in The Pink Sheet Daily
Executive Summary
As the Swiss drug giant builds a massive ophthalmology franchise, Alcon minority shareholders are pushing for a better deal.